Methods of using PVT1 exon 9 to diagnose and treat prostate cancer

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9845472
SERIAL NO

15345463

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Calculated Rating
US Family Size
Non-US Coverage
Patent Longevity
Forward Citations

Abstract

See full text

PVT1 exon 9 is overexpressed in aggressively tumorigenic prostate cancer cell lines and prostate tumor tissues. This exon provides a diagnostic tool for the detection and monitoring of aggressive prostate cancer. Several small interfering ribonucleic acids (siRNAs) are disclosed that are useful for treating prostate cancer.

First Claim

See full text

Other Claims data not available

Family

PCTEP
+

Patent Owner(s)

Patent OwnerAddress
RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK230 WEST 41ST STREET NEW YORK NY 10036-7207

International Classification(s)

loading....
  • 2016 Application Filing Year
  • C07H Class
  • 1039 Applications Filed
  • 891 Patents Issued To-Date
  • 85.76 % Issued To-Date
Click to zoom InYear of Issuance% of Matters IssuedCumulative IssuancesYearly Issuances20162017201820192020202120222023202420250255075100

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Ilboudo, Adeodat Bronx, US 3 3
Ogunwobi, Olorunseun O Yonkers, US 7 4
Ying, Chunxiao Forest Hills, US 3 3

Cited Art Landscape

Load Citation

Patent Citation Ranking

  • 0 Citation Count
  • C07H Class
  • 0 % this patent is cited more than
  • 8 Age
Citation count rangeNumber of patents cited in rangeNumber of patents cited in various citation count ranges233015571505030106334301 - 1011 - 2021 - 3031 - 4041 - 5051 - 6061 - 7071 - 8081 - 90100 +0200400600800100012001400160018002000220024002600

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Jun 19, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jun 19, 2029